Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Graves Ophthalmopathy

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Graves Ophthalmopathy in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, XL1
He, WM1
Li, W1
Zhang, L1
Grennan-Jones, F1
Draman, MS1
Lane, C1
Morris, D1
Dayan, CM1
Tee, AR1
Ludgate, M1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Graves Ophthalmopathy

ArticleYear
[Effects and Its Mechanism of IGF-1R on the Synthesis of Hyaluronic Acid in Orbital Fibroblasts of Thyroid Associated Ophthalmopathy].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2017, Volume: 48, Issue:5

    Topics: Cells, Cultured; Chromones; Fibroblasts; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Morpholines

2017
Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy.
    The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:7

    Topics: Adipogenesis; Cells, Cultured; Chromones; Drug Discovery; Gene Expression Regulation; Graves Ophthal

2014